## Abstract The aim of this study was to investigate associations between genetic variability in specific Glutathione __S__‐transferases (__GST__) genes (__GSTM1__, __GSTT1__ and __GSTP1__) and susceptibility to breast cancer. Genotypes of blood specimen DNA were determined for 65 women with incide
Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma
✍ Scribed by Hong Zhang; Ahmad Ahmadi; Gunnar Arbman; Johann Zdolsek; John Carstensen; Bo Nordenskjöld; Peter Söderkvistand; Xiao- Feng Sun
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- French
- Weight
- 59 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Gene codings for glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) are polymorphic in humans with null genotypes present in approximately 20 and 50%, respectively. A significant excess of homozygous null GSTT1 and GSTM1 genotypes has been demonstrated among individuals with certain types of cancers. This finding suggests that GSTT1 and GSTM1 may play a role in tumour susceptibility. However, reports concerning colorectal cancer susceptibility are controversial. In the present study, we used a multiplex polymerase chain reaction (PCR) approach to identify and analyze simultaneously the genotypes of both the genes in 99 patients with colorectal cancer and 109 healthy controls. Compared with the control group, a significant excess of homozygous null genotypes for GSTT1 was found in normal mucosa among the cancer patients, but not for GSTM1. Both genes were more frequently deleted in tumours than in corresponding normal mucosa. Furthermore, GSTT1 null genotype in tumour tissue, was significantly related to old age and to poor differentiation of tumours. GSTM1 null genotype in tumour was more frequent in the rectal tumours compared with tumours of left colon and right colon. Our results suggest that individuals with GSTT1 null genotype may be genetically predisposed for an increased risk of developing colorectal cancer. Allele loss in tumour tissue, which reflects genetic instability, may be considered as a marker for evaluating clinico-pathological characteristics of the cancer patients.
📜 SIMILAR VOLUMES
GSTs). Genetic variability in CYP and GST isoenzymes may